Cabergoline side effects steroids

The safety of Cabergoline has been evaluated in approximately 1,200 patients with Parkinson’s disease in controlled and uncontrolled studies at dosages of up to mg/day which greatly exceeds the maximum recommended dosage of Cabergoline for hyperprolactinemic disorders. In addition to the adverse events that occurred in the patients with hyperprolactinemic disorders, the most common adverse events in patients with Parkinson’s disease were dyskinesia, hallucinations, confusion, and peripheral edema. Heart failure, pleural effusion, pulmonary fibrosis, and gastric or duodenal ulcer occurred rarely. One case of constrictive pericarditis has been reported.

Cabergoline side effects steroids

cabergoline side effects steroids

Media:

cabergoline side effects steroidscabergoline side effects steroidscabergoline side effects steroidscabergoline side effects steroidscabergoline side effects steroids

http://buy-steroids.org